Over the last 10 years GlaxoSmithKline has grown to become New Zealand's largest supplier of asthma medicines.
The British pharma said its shot didn’t meet the efficacy goals of a Phase 2 study. Elsewhere, Zealand reported more obesity ...
Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...
GSK's specialty medicines segment showed strong performance, growing over 20% due to successful new launches. Additionally, GSK is currently undervalued, trading at £16.1, significantly below the ...
Bloomberg on MSN4mon
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at BayQuestions remain about GSK’s ability to come up with new drugs and litigation over the antacid Zantac, and the stock still ...
Analyst Graham Parry from Bank of America Securities maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) and keeping the ...
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...
Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on Wednesday night. | Several Big Pharmas took home trophies at the annual Fierce Pharma Marketing Awards on ...
After several years of anticipation, it’s a new GSK. And so far, the results look pretty good. The company, with facilities in Collegeville and Valley Forge, reported positive second quarter ...
Pharmaceutical giant GlaxoSmithKline (GSK) has been revealed as the top performing FTSE 100 business on gender equality, according to a new index. The Equity Index 2022/23 produced by Lead 5050 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback